Name (Synonyms) | Correlation | |
---|---|---|
drug129 | Blood donation from convalescent donor Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The study aims to systematically examine various aspects of the anxiety associated with the COVID-19 pandemic in Germany. The data collection is carried out online with longitudinal repeated measurements.
Description: To investigate specific fears regarding the COVID-19 pandemic 9 self created items are used. Values ranging from 1 to 6, higher scores indicate a worse outcome.
Measure: Characteristics of COVID-19-related anxiety Time: 1 dayDescription: Modified German version of the DSM-5 Severity-Measure-For-Specific-Phobia-Adult-Scale by Beesdo-Baum et al. (2014). 10 items, values ranging from 1 to 5, higher scores indicate a worse outcome. The Scale was adapted to anxiety symptoms related to COVID-19.
Measure: COVID-19-related anxiety symptoms Time: 1 dayDescription: Self-efficacy and coping with the COVID-19 pandemic are measured with 13 self created items. Values ranging from 1 to 6; higher scores indicate a better outcome (except inverted items).
Measure: Self-efficacy and coping with COVID-19 Time: 1 day + every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)Description: Personal consequences of the COVID-19 pandemic in the last three weeks are collected with five self-created items.
Measure: Consequences of COVID-19 in the last three weeks. Time: 1 day + every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)Description: General illness attitudes are measured with 3 subscales (Worry about illness; Thanatophobia; Bodily preoccupations) of the German version of the Illness Attitude Scales (IAS) by Hiller & Rief (2004). 9 Items; values ranging from 1 to 5, higher scores indicate a worse outcome.
Measure: General Illness Attitude Time: 1 day + every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)Description: Frequency, effects and formats of consumed media related to COVID-19 are measured with 5 self created items.
Measure: Media reporting Time: 1 day + every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)Description: To screen for general anxiety and depressive symptoms the German version of the Patient Health Questionnaire-4 (PHQ-4) by Löwe (2015) is used. 4 items; values ranging from 0 to 3, higher scores indicate a worse outcome.
Measure: Ultra-brief screening scale for anxiety and depression Time: 1 day + every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)Description: To investigate specific fears regarding the COVID-19 pandemic 9 self created items are used. Values ranging from 1 to 6, higher scores indicate a worse outcome.
Measure: Change in characteristics of COVID-19-related anxiety Time: Every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)Description: Modified German version of the DSM-5 Severity-Measure-For-Specific-Phobia-Adult-Scale by Beesdo-Baum et al. (2014). 10 items, values ranging from 1 to 5, higher scores indicate a worse outcome. The Scale was adapted to anxiety symptoms related to COVID-19.
Measure: Change in COVID-19-related anxiety symptoms Time: Every 3 weeks as long as the COVID-19 pandemic lasts (maximum: 30 weeks from baseline on) and one year later (Follow-Up)